Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1638
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17926970 | ONE-LOCUS INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE OR TEMPERATURE-INDUCIBLE PRECISION GUIDED STERILE INSECT TECHNIQUE | Non-Final OA | The Regents of the University of California |
| 17972875 | PREPARATION METHOD FOR ANIMAL MODEL OF ALZHEIMER'S DISEASE AND ANIMAL MODEL OF ALZHEIMER'S DISEASE PREPARED BY THE SAME | Non-Final OA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18255951 | TREATMENT OF CONGENITAL STATIONARY NIGHT BLINDNESS USING GENE THERAPY | Non-Final OA | INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE (INSERM) |
| 18039840 | Antibody Delivery | Non-Final OA | AC Immune SA |
| 18009192 | COMPOSITIONS AND METHODS FOR RED BLOOD CELL DIFFERENTIATION | Non-Final OA | The Children's Medical Center Corporation |
| 17623738 | CELL CULTURE SCAFFOLD, PRODUCTION METHOD THEREOF, SCAFFOLD PRODUCTION KIT, AND PRODUCTION METHOD OF CELL CULTURE PRODUCT | Non-Final OA | KINKI UNIVERSITY |
| 17637789 | CD24 EXPRESSING CELLS AND USES THEREOF | Final Rejection | Sana Biotechnology, Inc. |
| 18181952 | COMPOSITIONS AND METHODS FOR RECOMBINANT PARVOVIRUS PRODUCTION | Final Rejection | AAVNERGENE INC. |
| 17625442 | SPECIFIC MARKER FOR IDENTIFYING T CELLS SPECIFICALLY ATTACKING CANCER CELLS | Non-Final OA | Kotai Biotechnologies, Inc. |
| 18340765 | ORAL DELIVERY OF THERAPEUTIC MAMMALIAN CELLS | Non-Final OA | Vitabolus Inc. |
| 18036066 | RECOMBINANT ADENO-ASSOCIATED VIRUSES WITH ENHANCED LIVER TROPISM AND USES THEREOF | Non-Final OA | BEIJING SOLOBIO GENETECHNOLOGY CO., LTD |
| 18250873 | TISSUE SCAFFOLDS | Non-Final OA | JD BIOMEDICAL SOLUTIONS LTD. |
| 18177938 | Regulation of Gene Expression by Aptamer-Mediated Accessibility of Polyadenylation Signals | Non-Final OA | MeiraGTx Gene Regulation Limited |
| 18043276 | Genetic Construct | Final Rejection | Instituto de Medicina Molecular João Lobo Antunes |
| 18007602 | CELL LINES WITH MULTIPLE DOCKS FOR GENE INSERTION | Non-Final OA | CATALENT PHARMA SOLUTIONS, LLC |
| 17977476 | MESENCHYMAL STEM CELLS FOR THE PREVENTION AND TARGETED TREATMENT OF CANCER AND OTHER DISORDERS | Final Rejection | MAM Holdings of West Florida, L.L.C. |
| 17919890 | SUPER-ENCHANCERS FOR RECOMBINANT GENE EXPRESSION IN CHO CELLS | Non-Final OA | LEK Pharmaceuticals d.d. |
| 17995969 | iPSC INDUCTION | Final Rejection | Roslin Technologies Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy